References - Therapeutic Strategies in Cancer Biology and Pathology - page 245

Schmid, T., Bajer, M.M., Blees, J.S., Eifler, L.K., Milke, L., Ruebsamen, D., et al., 2011.
Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degrada-
tion. Carcinogenesis 32, 1427-1433.
Schnidar, H., Eberl, M., Klingler, S., Mangelberger, D., Kasper, M., Hauser-Kronberger, C.,
et al., 2009. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI
in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res.
69, 1284-1292.
Schreck, K.C., Taylor, P., Marchionni, L., Gopalakrishnan, V., Bar, E.E., Gaiano, N., et al.,
2010. The notch target hes1 directly modulates gli1 expression and hedgehog signaling: a
potential mechanism of gherapeutic resistance. Clin. Cancer Res. 16, 6060-6070.
Schultz, J., Ibrahim, S.M., Vera, J., Kunz, M., 2009. 14-3-3 sigma gene silencing during mela-
noma progression and its role in cell cycle control and cellular senescence. Mol. Cancer
8, 53.
Scobie, H.M., Young, J.A., 2005. Interactions between anthrax toxin receptors and protective
antigen. Curr. Opin. Microbiol. 8, 106-112.
Scott, G., Ahmad, I., Howard Km Maclean, D., Oliva, C., Warrington, S., Wilbraham, D.,
et al., 2013. Double-blind, randomized, placebo-controlled study of safety, tolerability,
pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin ana-
logue in healthy men. Br. J. Clin. Pharmacol. 75, 381-391.
Sebova, K., Zmetakova, I., Bella, V., Kajo, K., Stankovicova, I., Kajabova, V., et al., 2012.
RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer. Cancer
Biomark. 10, 13-26.
Sekimata, M., Kabuyama, Y., Emori, Y., Homma, Y., 1999. Morphological changes and
detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J.
Biol. Chem. 274, 17757-17762.
Selvanathan, S.P., Thakurta, A.G., Dhaksshnamoorthy, J., Zhou, M., Vennstra, T.D., Dhar,
R., 2010. Schizosaccharomyces pombe Dss1p is a DNA damage checkpoint protein that
recruits Rad24p, Cdc25p, and Rae1p to DNA double-strand breaks. J. Biol. Chem. 285,
14122-14133.
Semaan, A., Qazi, A.M., Seward, S., Chamala, S., Bryant, C.S., Kumar, S., et al., 2011.
MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-medi-
ated transcriptional repression of p21(waf1/cip1). Phamaceut. Res. 28, 3079-3090.
Serrano, M., 2000. The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 21,
865-869.
Setogawa, T., Shinozaki-Yabana, S., Masuda, T., Matsuura, K., Akiyama, T., 2006. The tumor
suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and
Ldb1. Biochem. Biophys. Res. Commun. 343, 1186-1190.
Sahab, Z.J., Man, Y.G., Semaan, S.M., Newcomer, R.G., Byers, S.W., Sang, Q.X.A., 2010.
Alteration in protein expression in estrogen receptor alpha-negative human breast can-
cer tissues indicates a malignant and metastatic phenotype. Clin. Exp. Metastasis 27,
493-503.
Shams, T.M., Samaka, R.M., Shams, M.E., 2006. Maspin protein expression: a special feature
of papillary thyroid carcinoma. J. Egypt. Nat. Cancer Inst. 18, 274-280. [Seen only as
Abstract]
Shank, J.J., Yang, K., Ghannam, J., Cabrera, L., Johnston, C.J., Reynolds, R.K., et al., 2012.
Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol. Oncol. 127,
390-397.
Sharma, G.D., He, J., Bazan, H.E., 2003. p38 and ERK1/2 coordinate cellular migration and
proliferation in epithelial wound healing: evidence of cross-talk activation between MAP
kinase cascades. J. Biol. Chem. 278, 21989-21997.